1534P First-line lenvatinib (len) plus pembrolizumab (pembro) and chemotherapy (chemo) for metastatic esophageal squamous cell carcinoma (mESCC): Safety run-in results from the phase III LEAP-014 study

J-M. Sun, Lin Shen, C. Rojas et al.|Annals of Oncology|2023

Cited by 5